» Articles » PMID: 35733227

Normothermic Regional Perfusion in Liver Transplantation from Donation After Cardiocirculatory Death: Technical, Biochemical, and Regulatory Aspects and Review of Literature

Abstract

Background: Organs from donation after circulatory death (DCD) are increasingly used for liver transplantation, due to the persisting organ shortage and waiting list mortality. However, the use of DCD grafts is still limited by the inferior graft survival rate and the increased risk of primary non-function and biliary complications when compared to brain death donors' grafts.

Methods: Abdominal normothermic regional perfusion with extracorporeal membrane oxygenation (ECMO) is an in situ preservation strategy. which may mitigate ischemia-reperfusion injuries. and has been proposed to restore blood perfusion after the determination of death thus optimizing liver function before implantation.

Results: In this systematic review, we highlighted the clinical evidence supporting the use of normothermic regional perfusion in DCD liver underlying the pathophysiological mechanisms, and technical, logistic, and regulatory aspects.

Conclusions: Despite the lack of properly designed, prospective, randomized trials, the current available data suggest beneficial effects of normothermic regional perfusion on clinical outcomes after liver transplantation.

Citing Articles

Thoracoabdominal Normothermic Regional Perfusion: Real-world Experience and Outcomes of DCD Liver Transplantation.

Bababekov Y, Ha A, Nydam T, Goncalves C, Choudhury R, Shinsako J Transplant Direct. 2025; 11(3):e1767.

PMID: 40034160 PMC: 11875611. DOI: 10.1097/TXD.0000000000001767.


Normothermic Regional Perfusion in Controlled Donation After Circulatory Death Liver Transplantation: A Systematic Review and Meta-Analysis.

Mastrovangelis C, Frost C, Hort A, Laurence J, Pang T, Pleass H Transpl Int. 2024; 37:13263.

PMID: 39246548 PMC: 11377255. DOI: 10.3389/ti.2024.13263.


Machine perfusion and the prevention of ischemic type biliary lesions following liver transplant: What is the evidence?.

Duran M, Calleja R, Hann A, Clarke G, Ciria R, Nutu A World J Gastroenterol. 2023; 29(20):3066-3083.

PMID: 37346149 PMC: 10280793. DOI: 10.3748/wjg.v29.i20.3066.


Bioenergetic and Cytokine Profiling May Help to Rescue More DCD Livers for Transplantation.

Hofmann J, Meszaros A, Buch M, Nardin F, Hackl V, Strolz C Int J Mol Sci. 2023; 24(11).

PMID: 37298486 PMC: 10253900. DOI: 10.3390/ijms24119536.


Introducing Machine Perfusion into Routine Clinical Practice for Liver Transplantation in the United States: The Moment Has Finally Come.

Croome K J Clin Med. 2023; 12(3).

PMID: 36769557 PMC: 9918031. DOI: 10.3390/jcm12030909.